Priority setting for pharmaceuticals: The use of health economic evidence by reimbursement and clinical guidance committees

By Anell Anders  

The European Journal of Health Economics, Vol. 5, Iss. 1, 2004-02 ,pp. : 28-35

Springer Publishing Company

Access to resources Recommend Favorite

Interpretation and use of FRAX in clinical practice

By Kanis J.   Hans D.   Cooper C.   Baim S.   Bilezikian J.   Binkley N.   Cauley J.   Compston J.   Dawson-Hughes B.   El-Hajj Fuleihan G.   Johansson H.   Leslie W.   Lewiecki E.   Luckey M.   Oden A.   Papapoulos S.   Poiana C.   Rizzoli R.   Wahl D.   McCloskey E.  

Osteoporosis International, Vol. 22, Iss. 9, 2011-09 ,pp. : 2395-2411

Springer Publishing Company

Access to resources Recommend Favorite

A clarification of the interdependence of clinical effectiveness and evidence-based practice

By Lipp A.  

Journal of Clinical Excellence, Vol. 4, Iss. 2, 2002-04 ,pp. : 217-222

Radcliffe Press

Access to resources Recommend Favorite

Use of extended-release niacin in clinical practice

By Suryadevara Ramya S   Karas Richard H   Kuvin Jeffrey T  

Future Lipidology, Vol. 3, Iss. 1, 2008-02 ,pp. : 9-16

Future Medicine

Access to resources Recommend Favorite

A multicentre analysis of troponin use in clinical practice

By Groarke J.   Browne L.   Margey R.   McCann H.   Blake G.   Sugrue D.   Mahon N.  

Irish Journal of Medical Science, Vol. 182, Iss. 2, 2013-06 ,pp. : 185-190

Springer Publishing Company

Access to resources Recommend Favorite